4 Dividend Stocks That Give You a Clean Taste

Published Mon, 16 Jan 2012 20:23 CET by DividendYields.org


Introduction
Since I like to take good care of my teeth, I use mouthwash after brushing. While gargling, I was annoyed that every time I screwed the cap back on the bottle of Listerine® (I drink from the cap, yes), a little bit of mouthwash dripped from the cap on the bottle and the shelf, making it all very sticky. The previous bottle of mouthwash I used was Elmex Sensitive. For some of you an unknown brand maybe, but they really did something very clever: they made a little drinking tube inside the cap! Lo and behold, no more mouthwash dripping out, no more sticky bottles!
What does this have to do with dividend investing? Well... nothing really. But it gave me the idea to take a look at the companies behind all those bottles of mouthwash and see how they're doing, dividend-wise. So here we go.

How to invest in a clean taste?
Since this website is about dividend investing, the focus will be on stocks paying out dividend. Luckily, most producers of mouthwash are well-known companies and listed on the New York Stock Exchange: Colgate Palmolive (NYSE: CL), GlaxoSmithKline (NYSE: GSK), Jonhson & Johnson (NYSE: JNJ) and Procter & Gamble (NYSE: PG). All companies except GlaxoSmithKline are also S&P 500 Dividend Aristocrats.

Colgate Palmolive
Colgate Palmolive is owner of the GABA Group, which produces Aronal, Elmex and Meridol mouth-/dental rinses in Therwil, Switzerland. Colgate Palmolive had a net income of USD 2.5 billion in the last 12 months and has paid uninterrupted dividends on its common stock since 1895 and increased payments to common shareholders every year for 48 years.

GlaxoSmithKline
GSK produces mouthwash under the name of Astring-O-Sol, made famous by model Joey Eastwood in the kissing booth TV commercial. GSK had a net income of GBP 3.3 billion (~USD 5 billion) in the last 12 months.
The graphs below show the Earnings Per Share (EPS) and Dividend Per Share of GSK.

GlaxoSmithKline EPS and Dividend per Share Graphs

Jonhson & Johnson
In 2006, Listerine® became a JNJ product with the acquiring of Pfizer Consumer Healthcare. Listerine® Antiseptic was created in 1879, making it the first-ever antiseptic mouthwash. JNJ is the world's sixth-largest consumer health company with a net income of USD 64 billion in the last 12 months. The JNJ stock has seen 49 consecutive years of dividend increases.

Procter & Gamble
Oral-B (since acquiring Gillette in 2005) and Scope are brands of mouthwash made by Procter & Gamble. P&G is the largest consumer goods company with a net income of USD 11.8 billion in 2011 and has paid uninterrupted dividends on its stock since 1890 and increased payments to shareholders every year for 54 years.

Name Dividend growth rate (5 years) EPS growth (5 years)
Colgate Palmolive 12.83% 12.17 USD
GlaxoSmithKline 8.12% -17.22 GBP
Jonhson & Johnson 10.60% 7.35 USD
Procter & Gamble 11.37% 10.18 USD


Disclosure: at the moment of writing, TopYields doesn't own any of the stocks mentioned.
Stock name Dividend Yield
Glaxosmithkline 4.92
Procter & Gamble 2.93
Johnson & Johnson 2.48
Colgate Palmolive 2.20

Articles featuring Glaxosmithkline (GSK):

'Safer' Dividend Follower Favorites And Rogues Led By Capitala Finance

Follower Selection Process From now on, when readers send me a message or comment on any of my new posts, any dividend stock mentioned might be included in a future follower favorite feature like this one. Therefore, both rogue and real favorites will appear on these lists in the future. Here are the tangible results for the follower favorites and rogues as of Sept. 15, 2017. Actionable Conclusions (1-10): Analysts Predicted 13.9% To 75.56% Net Gains For Top Ten "Safer"... Read more

Risk-Tolerant Healthcare Investors Should Look To Pharmaceutical Stocks For Dividend Income

Investors should consider healthcare stock classifications as a very diverse equity market. A mutual fund classified as “healthcare,” for example, can cover a wide range of businesses such as provider groups, pharmaceutical companies, health insurance companies, healthcare technology, and biotechnology. With the plethora of investment choices, income-oriented investors have numerous options when it comes to buying healthcare stocks that pay dividends. However, healthcare investors... Read more

GlaxoSmithKline Dividends Look More Attractive With New Management At The Helm

By S. Mitra, MBA (ISB) GlaxoSmithKline plc (NYSE: GSK) is one of the biggest dividend stocks in the pharma sector. With a dividend yield well over 6 percent, this dividend royalty is a staple of any income portfolio. However, the stock is currently way below its all-time high, mainly due to some rather tepid performance shown by the company. With a quickly dwindling product portfolio, the stock has not kept up with the performance shown by the broader market. The company may soon see some... Read more

'Safer' Dividend Follower Favorites And Rogues Led By RAIT Financial & Chico, Per August Gain Estimates

The Follower Selection Process From now on, when readers send me a message or comment on any of my new posts, any dividend stock mentioned may be included in a future follower favorite feature like this one. Therefore many more rogues may appear on these lists in the future. Here are the tangible results for the follower favorites & rogues as of August 15, 2017... Actionable Conclusions (1-10): Analysts Predicted 89% To 106.3% Net Gains For Top Ten "Safer" Dividend... Read more

HealthSouth Invades Big Pharma Duet To Place Atop 'Safer' Dividend Healthcare Pack For Gains In August

Actionable Conclusions (1-10): Brokers Bet Top Ten Healthcare "Safer" Dividend Dog Stocks to Net 5.1% to 20.8% Gains To August 2018 Six of ten top 'safer' dividend Healthcare dogs by yield (shaded in the chart above) were verified as being among the top ten gainers for the coming year. Based on analyst 1-year target prices, the dog strategy for this Health group as graded by analyst estimates for May proved 60% accurate. Ten probable profit generating trades were... Read more